Medicare Enrolled

Dr. Sukrut Dwivedi, D.O.

Infectious Disease · Oakhurst, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1912 STATE ROUTE 35, Oakhurst, NJ 07755
7322224762
In practice since 2008 (18 years)
NPI: 1003082660 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dwivedi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dwivedi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dwivedi

Dr. Sukrut Dwivedi is an infectious disease specialist in Oakhurst, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dwivedi performed 6,468 Medicare services across 3,515 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dwivedi received a total of $76,861 from 29 pharmaceutical and/or device companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dwivedi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 7% volume in NJ $76,861 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,468
Medicare services
Top 7% in NJ for infectious disease
3,515
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~359 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
2,886 $64 $98
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
2,144 $95 $145
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
589 $145 $276
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
492 $109 $205
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
108 $99 $187
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
57 $141 $255
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
48 $57 $101
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $67 $121
Venipuncture for blood draw
Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older.
26 $15 $25
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
17 $11 $19
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
16 $85 $145
Prolonged inpatient or observation care, each additional 15 minutes
This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider.
15 $25 $35
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $137 $208
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
12 $57 $110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
0.0% medium
99.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$76,861
Total received (2018-2024)
Avg $10,980/year across 7 years
Top 4% in NJ for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
353
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$72,680 (94.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,410 (3.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,772 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,462
2023
$7,172
2022
$16,044
2021
$17,055
2020
$7,032
2019
$15,876
2018
$9,220

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,396
ViiV Healthcare Company
$1,772
Insmed, Inc.
$70
Gilead Sciences, Inc.
$66
AIMMUNE THERAPEUTICS, INC.
$46
Shionogi Inc
$36
Astellas Pharma US Inc
$34
Paratek Pharmaceuticals, Inc.
$29
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 95.0% of 2024 payments
All-time payments by company (2018-2024) ›
Paratek Pharmaceuticals, Inc.
$24,113
Allergan Inc.
$12,737
Merck Sharp & Dohme Corporation
$11,992
AbbVie Inc.
$9,945
ABBVIE INC.
$7,262
Allergan, Inc.
$6,659
ViiV Healthcare Company
$2,408
Gilead Sciences, Inc.
$457
Insmed, Inc.
$333
Merck Sharp & Dohme LLC
$123
Silk Road Medical, Inc.
$122
Smith+Nephew, Inc.
$111
Melinta Therapeutics, LLC
$89
Astellas Pharma US Inc
$86
Melinta Therapeutics, Inc.
$61
Janssen Biotech, Inc.
$60
AIMMUNE THERAPEUTICS, INC.
$60
Shionogi Inc
$54
Theratechnologies Inc.
$30
AbbVie, Inc.
$25
Philips Electronics North America Corporation
$19
Ferring Pharmaceuticals Inc.
$17
TETRAPHASE PHARMACEUTICALS, INC.
$15
Theravance Biopharma, Inc.
$15
Dynavax Technologies Corporation
$15
Vyera Pharmaceuticals, LLC
$14
Nabriva Therapeutics, plc
$14
AstraZeneca Pharmaceuticals LP
$13
Romark Laboratories, LC
$12
Top 3 companies account for 63.5% of all-time payments
Associated products mentioned in payments ›
ALINIA · APRETUDE · AVYCAZ · Arikayce · Baxdela · CABENUVA · CRESEMBA · Cresemba · DALVANCE · DIFICID · DOVATO · Daraprim 30 Tablet in 1 Bottle · EGRIFTA · ENROUTE Transcarotid Neuroprotection System · EVUSHELD · Fetroja · Heplisav-B · ISENTRESS · Kimyrsa · MAVYRET · MYCAMINE · Mavyret · NUZYRA · PIFELTRO · PREVYMIS · REBYOTA · RENFLEXIS · SYMTUZA · Santyl · TEFLARO · TRIUMEQ · VIBATIV · VOWST · Vabomere · Xenleta · Xerava · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for infectious disease in NJ.

Looking for an infectious disease specialist in Oakhurst?
Compare infectious diseases in the Oakhurst area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
63
Per 100K population
9.8
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dwivedi is a mixed practice specialist, with above-average Medicare volume (top 7% in NJ), with speaking/promotional industry engagement in the top 4% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dwivedi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Dwivedi performed 2,886 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dwivedi receive payments from pharmaceutical companies?
Yes. Dr. Dwivedi received a total of $76,861 from 29 companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dwivedi's costs compare to other infectious diseases in Oakhurst?
Dr. Dwivedi's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dwivedi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →